DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Absci Corporation
publicFounded 2011

Absci Corporation

HQ: Vancouver, WA, USACEO: Sean McClainHeadcount: 300+absci.com
Funding Summary
Total Funding
$500M+
Latest Valuation
~$500M (public market cap)
About

Combines generative AI with proprietary wet lab validation (SoluPro) for de novo antibody design, reducing drug discovery from years to months.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →
Referenced In